UPC Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

7.310

Open

6.000

VWAP

6.45

Vol

186.85K

Mkt Cap

3.56M

Low

5.720

Amount

1.21M

EV/EBITDA(TTM)

Total Shares

563.34K

-20.45M

EV/OCF(TTM)

P/S(TTM)

0.15

Universe Pharmaceuticals Inc is a holding company primarily engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine drugs (TCMDs) products targeting the elderly. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The Company is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.

Events Timeline

(ET)

2026-06-26

16:30:00

Universe Pharmaceuticals Acquires 100% of Best Praise International for $10.751M

2024-12-09 (ET)

2024-12-09

06:11:13

Universe Pharmaceuticals to sell 18.75M shares at 80c in direct offering

2024-11-01 (ET)

2024-11-01

16:03:26

Universe Pharmaceuticals receives Nasdaq notification over bid price deficiency

News

8.5

06-30NASDAQ.COM

Universe Pharma Acquires Patent Portfolio, Shares Surge

8.5

06-29Newsfilter

Universe Pharmaceuticals Acquires Best Praise International

8.5

06-27NASDAQ.COM

Universe Pharmaceuticals Acquires Best Praise International for $10.75 Million

8.5

06-26stocktwits

Universe Pharmaceuticals Acquires Patent Portfolio to Expand Business

8.5

06-26seekingalpha

Universe Pharmaceuticals Acquires Best Praise International for $10.75M

8.5

06-26Newsfilter

Universe Pharmaceuticals Acquires Best Praise International Limited

Valuation Metrics

The current forward P/E ratio for Universe Pharmaceuticals Inc (UPC.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Universe Pharmaceuticals Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stocks with low shares available to short

Intellectia · 43 candidates

Region: USRelative Vol: >= 1.50Short Ratio: LessThan10PctList Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

CMCSA

Comcast Corp

86.52B

UPC

Universe Pharmaceuticals Inc

1.67M

Dynatrace, Inc

12.89B

VRDN

Viridian Therapeutics Inc

2.07B

IFRX

InflaRx NV

282.80M

BGC

Bgc Group Inc

5.49B

list of IPO from 2023

Intellectia · 1210 candidates

Region: USFloating Shares: <= 20,000,000

Ticker

Name

Market Cap$

LGHL

Lion Group Holding Ltd

623.70K

RAYA

Erayak Power Solution Group Inc

684.91K

BDRX

Biodexa Pharmaceuticals PLC

792.57K

ADTX

Aditxt Inc

829.40K

BNRG

Brenmiller Energy Ltd

859.02K

TRNR

Interactive Strength Inc

865.12K

what stocks have a small float?

Intellectia · 2475 candidates

List Exchange: XNYS, XNAS, XASEFloating Shares: <= 50,000,000

Ticker

Name

Market Cap$

STRC

Strategy Inc

42.03B

DIT

Amcon Distributing Co

71.58M

SLGL

Sol Gel Technologies Ltd

172.80M

SEB

Seaboard Corp

4.77B

IOR

Income Opportunity Realty Investors Inc

73.19M

LYRA

Lyra Therapeutics Inc

3.59M

Whales Holding UPC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Universe Pharmaceuticals Inc (UPC) stock price today?

The current price of UPC is 6.32 USD — it has increased 5.33

What is Universe Pharmaceuticals Inc (UPC)'s business?

What is the price predicton of UPC Stock?

Wall Street analysts forecast UPC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.